Opposing interplay between Neuropeptide FF and nitric oxide in antinociception and hypothermia

Peptides

Volumn 21, Issue 8, 2000, Pages 1209-1213

  Zajac, Jean Marie ^a   Latapie, Jean Philippe ^a   Francés, Bernard ^a  

^a CNRS   (France)

Author keywords

Analgesia; Hypothermia; Mouse; Neuropeptide FF (NPFF); Nitric oxide (NO)

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NALOXONE; NEUROPEPTIDE FF; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; HOT PLATE TEST; HYPOTHERMIA; IMMUNOREACTIVITY; MEMBRANE DEPOLARIZATION; MOLECULAR CLONING; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; THERMOREGULATION; VASCULAR SMOOTH MUSCLE;

ANALGESICS, OPIOID; ANIMAL; AREA UNDER CURVE; ARGININE; BODY TEMPERATURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FREE RADICAL SCAVENGERS; HYPOTHERMIA; MALE; MICE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; OLIGOPEPTIDES; PAIN; SUPPORT, NON-U.S. GOV'T; TEMPERATURE;

EID: 0033790980     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(00)00261-8     Document Type: Article

References (35)

1. Ballet S., Mauborgne A., Gouarderes C., et al. The Neuropeptide FF analogue, 1DMe, enhances in vivo met enkephalin release from the rat spinal cord. Neuropharmacology. 38:1999;1317-1324.
2. Besson J-M. The neurobiology of pain. Lancet. 353:1999;1610-1615.
3. Chaplan S.R., Pogrel J.W., Yaksh T.L. Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. J Pharmacol Exp Ther. 269:1994;1117-1123.
4. Chen J.C., Li J.Y., Liang K.W., Huang Y.K. Neuropeptide FF potentiates the behavioral sensitization to amphetamine and alters the levels of neurotransmitters in the medial prefrontal cortex. Brain Res. 816:1999;220-224.
5. Dambisya Y.M., Lee T.L. Effects of L-NG-nitro arginine methyl ester (L-NAME), L-NG-monomethyl arginine (L-NMMA) and L-arginine on the antinociceptive effects of morphine in mice. Methods Find Exp Clin Pharmacol. 17:(9):1995;577-582.
6. Desprat C., Zajac J-M. Hypothermic effects of Neuropeptide FF analogues in mice. Pharmacol Biochem Behav. 58:1997;559-563.
7. Devillers J.P., Simonnet G. Modulation of Neuropeptide FF release from rat spinal cord slices by glutamate. Involvement of NMDA receptors. Eur J Pharmacol. 271:1994;185-192.
8. Dickenson A.H. Central acute pain mechanisms. Ann Med. 28:(2):1995;223-227.
9. Dickenson A.H., Chapman V., Green G.M. The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord. Gen Pharmacol. 28:1997;633-638.
10. Dunbar S., Yaksh T. Effect of spinal infusion of L-NAME, a nitric oxide synthase inhibitor, on spinal tolerance and dependence induced by chronic intrathecal morphine in the rat. Neurosci Lett. 207:1996;33-36.
11. Furst S. Transmitters involved in antinociception in the spinal cord. Brain Res Bull. 48:1999;129-141.
12. Gelot A., Francés B., Gicquel S., Zajac J-M. Antisense oligonucleotides to human SQA-Neuropeptide FF decrease morphine tolerance and dependence in mice. Eur J Pharmacol. 358:1998a;203-206.
13. Gelot A., Francés B., Roussin A., Latapie J.P., Zajac J-M. Anti-opioid efficacy of Neuropeptide FF in morphine-tolerant mice. Brain Res. 808:1998b;166-173.
14. Gicquel S., Mazarguil H., Allard M., Simonnet G., Zajac J-M. Analogs of F8Famide resistant to degradation, with high affinity and in vivo effects. Eur J Pharmacol. 222:1992;61-67.
15. Gouardères C., Jhamandas K., Sutak M., Zajac J-M. Role of opioid receptors in the spinal antinociceptive effects of Neuropeptide FF analogues. Br J Pharmacol. 117:1996;493-501.
16. Gouardères C., Tafani J.A., Zajac J.M. Affinity of neuropeptide FF analogs to opioid receptors in the rat spinal cord. Peptides. 19:1998;727-730.
17. Kolesnikov Y.A., Pick C.G., Pasternak G.W. NG-nitro-L-arginine prevents morphine tolerance. Eur J Pharmacol. 221:1992;399-400.
18. Lake J.R., Hammond M.V., Shaddox R.C., Hunsicker L.M., Yang H.-Y.T., Malin D.H. IgG from Neuropeptide FF antiserum reverses morphine tolerance in the rat. Neurosci Lett. 132:1991;29-32.
19. Lee Y.W., Yaksh T.L. Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists. J Pharmacol Exp Ther. 277:1996;1642-1648.
20. 2-like mammalian octapeptide possible role in opiate dependence and abstinence. Peptides. 11:1990;969-972.
21. Malin D.H., Lake J.R., Jones J.A., et al. Nitric oxide synthesis inhibition attenuates behavioral actions of Neuropeptide FF. Peptides. 17:1996;615-618.
22. Moore P.K., Handy R.L.C. Selective inhibitors of neuronal nitric oxide synthase- is no NOS really good NOS for the nervous system? TIPS. 18:1997;204-211.
23. Moore P.K., Oluyomi A.O., Babbedge R.C., Wallace P., Hart S.L. L-NG-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Brit J Pharmacol. 102:1991;198-202.
24. Mustafa A.A. Mechanisms of L-NG-nitro arginine methyl ester-induced antinociception in mice a role for serotoninergic and adrenergic neurons. Gen Pharmacol. 23:1992;1177-1182.
25. Pataki I., Telegdy G. Further evidence that nitric oxide modifies acute and chronic morphine actions in mice. Eur J Pharmacol. 357:1998;157-162.
26. Perry S.J., Huang E.Y., Cronk D., et al. A human gene encoding morphine modulating peptides related to NPFF and FMRFamide. FEBS Lett. 409:1997;426-430.
27. Przewlocki R., Machelska H., Przewlocka B. Inhibition of nitric oxide synthase enhances morphine antinociception in the rat spinal cord. Life Sci. 53:1993;L1-PL5.
28. Roumy M., Zajac J-M. Neuropeptide FF, pain and analgesia. Eur J Pharmacol. 345:1998;1-11.
29. Scammell T.E., Elmquist J.K., Saper C.B. Inhibition of nitric oxide synthase produces hypothermia and depresses lipopolysaccharide fever. Am J Physiol. 271:1996;333-338.
30. Spina E., Trovati A., Parolaro D., Giagnoni G. A role of nitric oxide in WIN 55,212-2 tolerance in mice. Eur J Pharmacol. 55:1999;804-811.
31. Vilim F.S., Aarrnisalo A.A., Nieminen M.-L., et al. Gene for pain modulatory neuropeptide NPFF induction in spinal cord by noxious stimuli. Mol Pharmacol. 55:1999;804-811.
32. Wang J., Ando T., Dunn A.J. Effect of homologous interleukin-1 (IL-1), IL-6 and tumor necrosis factor (TNF)-α on the core body temperature of mice. Neuroimmunomodulation. 4:1997;230-236.
33. Yang H.-Y.T., Fratta W., Majane E.A., Costa E. Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc Natl Acad Sci USA. 82:1985;7757-7761.
34. Yaksh T.L. Spinal systems and pain processing development of novel analgesic drugs with mechanistically defined models. Trends Pharmacol Sci. 20:1985;329-337.
35. 4]deltorphin II, a delta2-opioid receptor agonist in mice. Peptides. 17:1996;619-623.